Product Information
ESTRADIOL VALERATE 200 MG/5 ML is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $36.8279 per ML under NDC 00143929101. Its NADAC has been published 274 times since Jul 7, 2021.
FDA first approved this application on Apr 21, 2020. Its Orange Book therapeutic-equivalence code is AO.
Strength
40 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143929101
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
ESTRADIOL VALERATEApproval Type
Generic (ANDA)
FDA Application
ANDA203723FDA Approved
4/21/2020
TE Code
AO
On Market Since
4/21/2020
Pharmacological Classes
Price Statistics
The NADAC for ESTRADIOL VALERATE 200 MG/5 ML has been published 274 times since Jul 7, 2021, and over the history we have for it it has risen 14.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $36.8279 per ML |
|---|---|
| All-time high | $38.6398 (Nov 12, 2025) |
| All-time low | $24.9823 (Nov 20, 2024) |
| 52-week high | $38.6398 |
| 52-week low | $33.6338 |
| Median price | $33.7100 |
| Average price | $33.5658 |
| Largest weekly change | +33.8% (Oct 18, 2023) |
| Weeks tracked | 274 |
| Tracking since | Jul 7, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Estradiol Valerate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Estradiol Valerate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ESTRADIOL VALERATE 200 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for ESTRADIOL VALERATE 200 MG/5 ML, manufactured by Hikma Pharmaceuticals USA Inc., is $36.8279 per ML (NDC 00143929101), effective Sep 30, 2026.
How has the price of ESTRADIOL VALERATE 200 MG/5 ML changed over time?
Over the history we have for it, the NADAC for ESTRADIOL VALERATE 200 MG/5 ML has risen 14.3%. It has been tracked across 274 weekly CMS publications since Jul 7, 2021.
What are the highest and lowest recorded NADAC prices for ESTRADIOL VALERATE 200 MG/5 ML?
Since Jul 7, 2021, the NADAC for ESTRADIOL VALERATE 200 MG/5 ML has ranged from a low of $24.9823 (Nov 20, 2024) to a high of $38.6398 (Nov 12, 2025), with a median of $33.7100 per ML.
Are there cheaper alternatives to ESTRADIOL VALERATE 200 MG/5 ML?
No other NADAC-published product currently shares the active ingredient and strength of ESTRADIOL VALERATE 200 MG/5 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ESTRADIOL VALERATE 200 MG/5 ML?
ESTRADIOL VALERATE 200 MG/5 ML (NDC 00143929101) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.